|
1
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fulda S and Debatin KM: Apoptosis
signaling in tumor therapy. Ann NY Acad Sci. 1028:150–156. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verheij M and Bartelink H:
Radiation-induced apoptosis. Cell Tissue Res. 301:133–142. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pommier Y, Sordet O, Antony S, Hayward RL
and Kohn KW: Apoptosis defects and chemotherapy resistance:
Molecular interaction maps and networks. Oncogene. 23:2934–2949.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S,
Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety of
sorafenib in patients in the Asia-Pacific region with advanced
hepatocellular carcinoma: A phase III randomised, double-blind,
placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du X, Bao G, He X, Zhao H, Yu F, Qiao Q,
Lu J and Ma Q: Expression and biological significance of c-FLIP in
human hepatocellular carcinomas. J Exp Clin Cancer Res. 28:24–31.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fleischer B, Schulze-Bergkamen H,
Schuchmann M, Weber A, Biesterfeld S, Müller M, Krammer PH and
Galle PR: Mcl-1 is an anti-apoptotic factor for human
hepatocellular carcinoma. Int J Oncol. 28:25–32. 2006.PubMed/NCBI
|
|
8
|
Augello C, Caruso L, Maggioni M, Donadon
M, Montorsi M, Santambrogio R, Torzilli G, Vaira V, Pellegrini C,
Roncalli M, et al: Inhibitors of apoptosis proteins (IAPs)
expression and their prognostic significance in hepatocellular
carcinoma. BMC Cancer. 9:125–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen JH, Chen WL and Liu YC: Amentoflavone
induces anti-angiogenic and anti-metastatic effects through
suppression of NF-κB activation in MCF-7 cells. Anticancer Res.
35:6685–6693. 2015.PubMed/NCBI
|
|
10
|
Baud V and Karin M: Is NF-kappaB a good
target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov.
8:33–40. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsu FT, Liu YC, Chiang IT, Liu RS, Wang
HE, Lin WJ and Hwang JJ: Sorafenib increases efficacy of vorinostat
against human hepatocellular carcinoma through transduction
inhibition of vorinostat-induced ERK/NF-κB signaling. Int J Oncol.
45:177–188. 2014.PubMed/NCBI
|
|
12
|
Hsu FT, Liu YC, Liu TT and Hwang JJ:
Curcumin sensitizes hepatocellular carcinoma cells to radiation via
suppression of radiation-induced NF-κB activity. Biomed Res Int.
2015:3636712015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin Y, Chen J, Feng Z, Fan W, Wang Y, Li J
and Tong D: The expression of Survivin and NF-κB associated with
prognostically worse clinicopathologic variables in hepatocellular
carcinoma. Tumour Biol. 35:9905–9910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ravi S and Singal AK: Regorafenib: An
evidence-based review of its potential in patients with advanced
liver cancer. Core Evid. 9:81–87. 2014.PubMed/NCBI
|
|
15
|
Tai WT, Chu PY, Shiau CW, Chen YL, Li YS,
Hung MH, Chen LJ, Chen PL, Su JC, Lin PY, et al: STAT3 mediates
regorafenib-induced apoptosis in hepatocellular carcinoma. Clin
Cancer Res. 20:5768–5776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma CY, Ji WT, Chueh FS, Yang JS, Chen PY,
Yu CC and Chung JG: Butein inhibits the migration and invasion of
SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK,
JNK, p38, and uPA signaling multiple pathways. J Agric Food Chem.
59:9032–9038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chiang IT, Liu YC, Wang WH, Hsu FT, Chen
HW, Lin WJ, Chang WY and Hwang JJ: Sorafenib inhibits TPA-induced
MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in
hepatocellular carcinoma cells. In Vivo. 26:671–681.
2012.PubMed/NCBI
|
|
18
|
Wang WH, Chiang IT, Ding K, Chung JG, Lin
WJ, Lin SS and Hwang JJ: Curcumin-induced apoptosis in human
hepatocellular carcinoma j5 cells: Critical role of
Ca+2-dependent pathway. Evid Based Complement Alternat
Med. 2012:5129072012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang SH, Wu LW, Huang AC, Yu CC, Lien JC,
Huang YP, Yang JS, Yang JH, Hsiao YP, Wood WG, et al: Benzyl
isothiocyanate (BITC) induces G2/M phase arrest and
apoptosis in human melanoma A375.S2 cells through reactive oxygen
species (ROS) and both mitochondria-dependent and death
receptor-mediated multiple signaling pathways. J Agric Food Chem.
60:665–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ting CY, Wang HE, Yu CC, Liu HC, Liu YC
and Chiang IT: Curcumin triggers DNA damage and inhibits expression
of DNA repair proteins in human lung cancer cells. Anticancer Res.
35:3867–3873. 2015.PubMed/NCBI
|
|
21
|
Liu H, Yang J, Yuan Y, Xia Z, Chen M, Xie
L, Ma X, Wang J, Ouyang S, Wu Q, et al: Regulation of Mcl-1 by
constitutive activation of NF-κB contributes to cell viability in
human esophageal squamous cell carcinoma cells. BMC Cancer.
14:98–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scott FL, Denault JB, Riedl SJ, Shin H,
Renatus M and Salvesen GS: XIAP inhibits caspase-3 and −7 using two
binding sites: Evolutionarily conserved mechanism of IAPs. EMBO J.
24:645–655. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perciavalle RM and Opferman JT: Delving
deeper: MCL-1's contributions to normal and cancer biology. Trends
Cell Biol. 23:22–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morciano G, Giorgi C, Balestra D, Marchi
S, Perrone D, Pinotti M and Pinton P: Mcl-1 involvement in
mitochondrial dynamics is associated with apoptotic cell death. Mol
Biol Cell. 27:20–34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen D, Wei L, Yu J and Zhang L:
Regorafenib inhibits colorectal tumor growth through PUMA-mediated
apoptosis. Clin Cancer Res. 20:3472–3484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmitz KJ, Wohlschlaeger J, Lang H,
Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR,
Schmid KW and Baba HA: Activation of the ERK and AKT signalling
pathway predicts poor prognosis in hepatocellular carcinoma and ERK
activation in cancer tissue is associated with hepatitis C virus
infection. J Hepatol. 48:83–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu L, Cao Y, Chen C, Zhang X, McNabola A,
Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the
RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor
cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer
Res. 66:11851–11858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng JC, Chou CH, Kuo ML and Hsieh CY:
Radiation-enhanced hepatocellular carcinoma cell invasion with
MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction
pathway. Oncogene. 25:7009–7018. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH,
Kim WK and Kim HS: Curcumin suppresses phorbol ester-induced matrix
metalloproteinase-9 expression by inhibiting the PKC to MAPK
signaling pathways in human astroglioma cells. Biochem Biophys Res
Commun. 335:1017–1025. 2005. View Article : Google Scholar : PubMed/NCBI
|
